Hypolipidemic effects of kaempferide-7-O-(4″-O-acetylrhamnosyl) -3-O-rutinoside in hyperlipidemic rats induced by a high-fat diet

Molecular Medicine Reports

Volumn 5, Issue 3, 2012, Pages 837-841

  Zhao, Xue Zhong ^a   Li, Xu Wen ^b   Jin, Yong Ri ^b   Yu, Xiao Feng ^a   Qu, Shao Chun ^a   Sui, Da Yuan ^a  

^a JILIN UNIVERSITY   (China)

^b School of Pharmacy   (China)

Author keywords

High fat diet; Hypolipidemic; Kaempferide 7 O (4 O acetylrhamnosyl) 3 O rutinoside

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; KAEMPFERIDE 7 O (4'' O ACETYLRHAMNOSYL) 3 O RUTINOSIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; PHOSPHATIDATE PHOSPHATASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENIC INDEX; CARDIOVASCULAR PARAMETERS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY RISK INDEX; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; ENZYME ACTIVITY; HEART INDEX; HYPERLIPIDEMIA; LIPID DIET; LIVER; MALE; NONHUMAN; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

ACTINIDIA; ANIMALS; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIET, HIGH-FAT; ENZYME ACTIVATION; GLYCOSIDES; HYDROXYMETHYLGLUTARYL COA REDUCTASES; HYPERLIPIDEMIAS; HYPOLIPIDEMIC AGENTS; KAEMPFEROLS; LOVASTATIN; MALE; PHOSPHATIDATE PHOSPHATASE; PLANT EXTRACTS; PLANT LEAVES; RATS; RATS, WISTAR; TRIGLYCERIDES;

ACTINIDIA KOLOMIKTA; RATTUS; RATTUS NORVEGICUS;

EID: 84863034635     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2011.714     Document Type: Article

References (17)

1. Chen Z, Peto R, Collins R, MacMahon S, Lu J and Li W: Serum cholesterol concentration and coronary heart disease in a population with low cholesterol concentrations. BMJ 303: 276-282, 1991.
2. McKenney JM: Pharmacotherapy of dyslipidemia. Cardiovasc Drugs Ther 15: 413-422, 2001.
3. Aronow WS: Treatment of high-risk older persons with lipid-lowering drug therapy. Am J Ther 15: 102-107, 2008.
4. Rush EC, Patel M, Plank LD and Ferguson LR: Kiwifruit promotes laxation in the elderly. Asia Pac J Clin Nutr 11: 164-168, 2002. (Pubitemid 34864643)
5. Dawes HM and Keene JB: Phenolic composition of kiwifruit juice. J Agric Food Chem 47: 2398-2403, 1999. (Pubitemid 29325130)
6. Fiorentino A, D'Abrosca B, Pacifico S, Mastellone C, Scognamiglio M and Monaco P: Identification and assessment of antioxidant capacity of phytochemicals from kiwi fruits. J Agric Food Chem 57: 4148-4155, 2009.
7. Collins AR, Harrington V, Drew J and Melvin R: Nutritional modulation of DNA repair in a human intervention study. Carcinogenesis 24: 511-515, 2003. (Pubitemid 36432648)
8. Zhang L, Yang J, Chen XQ, et al: Antidiabetic and antioxidant effects of extracts from Potentilla discolor Bunge on diabetic rats induced by high fat diet and streptozotocin. J Ethnopharmacol 132: 518-524, 2010.
9. Park KW, Lee JE and Park KM: Diets containing Sophora japonica L. prevent weight gain in high-fat diet-induced obese mice. Nutr Res 29: 819-824, 2009.
10. Mulvihill EE, Assini JM, Sutherland BG, et al: Naringenin decreases progression of atherosclerosis by improving dyslipidemia in high-fat-fed low-density lipoprotein receptor-null mice. Arterioscler Thromb Vasc Biol 30: 742-748, 2010.
11. Adeneye AA, Adeyemi OO and Agbaje EO: Anti-obesity and antihyperlipidaemic effect of Hunteria umbellata seed extract in experimental hyperlipidaemia. J Ethnopharmacol 130: 307-314, 2010.
12. Haghighi B and Honarjou S: The effects of hydrazine on the phosphatidate phosphohydrolase activity in rat liver. Biochem Pharmacol 36: 1163-1165, 1987. (Pubitemid 17051109)
13. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951.
14. Rao AV and Ramakrishnan S: Indirect assessment of hydroxymethylglutaryl- CoA reductase (NADPH) activity in liver tissue. Clin Chem 21: 1523-1525, 1975.
15. Berliner JA and Heinecke JW: The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med 20: 707-727, 1996. (Pubitemid 26105783)
16. Hegele RA and Pollex RL: Genetic and physiological insights into the metabolic syndrome. Am J Physiol Regul Integr Comp Physiol 289: R663-R669, 2005. (Pubitemid 41208429)
17. Rozman D and Monostory K: Perspectives of the non-statin hypolipidemic agents. Pharmacol Ther 127: 19-40, 2010.